arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Microbot Medical Inc.

MBOT
$1.89 ▲ +0.09 (+5.00%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
67 Visible periods
27 Metrics
Peer-ranked Benchmarks
Price Chart
39
Health
Weak
Neutral
auto_awesome

Analytical Summary

Microbot Medical Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $126.9M
Dividend Yield
Revenue Growth None
Op. Margin
ROIC -4.6%
FCF / Share $-0.08
Trailing P/E
Price / Book 1.7x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

67-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$105.00K
↑ +220.5%
Net Income Profit after all expenses
$-3.67M
↓ -41.1%
FCF / Share Free cash flow per share
$-0.08
↑ +17.3%
Long-Term Debt Long-term obligations
$17.50K
↓ -75.4%

Health Breakdown

Returns
29
Cash Quality
65

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 67 quarters